(Total Views: 159)
Posted On: 03/29/2023 10:14:57 AM
Post# of 103502
$COEP NASDAQ: COEP: Potential acquisition of VyGen-Bio $COEP; Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Multiple Cancers: Coeptis Therapeutics
https://finance.yahoo.com/news/coeptis-therap...00044.html
https://finance.yahoo.com/news/coeptis-therap...00044.html
(0)
(0)Scroll down for more posts ▼
